Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token.
Why this matters
This cryptocurrency story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on CointelegraphRelated market context
Ukraine deploys unmanned vehicles to frontline, shifting military strategy
Ukraine's use of unmanned vehicles may redefine modern warfare, reducing human risk and influencing global military strategies. Th...
Coinbase-backed Base just exposed the uncomfortable truth about Ethereum’s L2s
Ethereum and Coinbase-backed layer-2 network Base have abandoned an effort to agree on how the next generation of crypto wallets s...
Strategy Buys Back Stock, Skips Bitcoin Purchase
Bitcoin Magazine Strategy Buys Back Stock, Skips Bitcoin Purchase Bitcoin treasury Strategy held off buying bitcoin again last wee...
Zcash Mining Highly Profitable: Grayscale Says Rewards Beat Bitcoin 2x
Zcash mining rewards are roughly twice Bitcoin’s per machine and four times higher per unit of electricity, Grayscale estimates. S...
UK Lords Defeat Government 194-138 Over Crypto Strategy
The United Kingdom government has suffered a House of Lords defeat after peers voted 194-138 to require the Treasury to produce a...
Privacy Coins Outrun Bitcoin as Market Rotates Into Zcash and Monero
Privacy coins have broken away from a weak crypto market, with zcash and monero delivering gains while bitcoin remains below its O...